| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |